![Ravi Rao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
El Dr. Ravi M. Rao es director médico de Swedish Orphan Biovitrum AB y miembro del Royal College of Physicians. Forma parte del Consejo de Administración de DBV Technologies SA. Anteriormente, el Dr. Rao trabajó como Director Médico en Aeglea Biotherapeutics, Inc. y como Jefe de Asuntos Médicos Globales en GlaxoSmithKline Plc. Se licenció en la Universidad de Cambridge y se doctoró en el Imperial College de Londres.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DBV TECHNOLOGIES | Director/Miembro de la Junta | 19/05/2021 |
| AUTOLUS THERAPEUTICS PLC | Director/Miembro de la Junta | 01/04/2024 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Director Técnico/Científico/I+D | 01/04/2022 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Inversor de Capital Privado | 01/03/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01/11/2023 |
| SWEDISH ORPHAN BIOVITRUM AB | Director Técnico/Científico/I+D | 01/01/2022 |
| SPYRE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 10/08/2020 |
| GSK PLC | Director Técnico/Científico/I+D | 01/10/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
